Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Silence Therapeutics (SLNCF) Non-Current Receivables (2019 - 2020)

Historic Non-Current Receivables for Silence Therapeutics (SLNCF) over the last 2 years, with Q2 2020 value amounting to $40.9 million.

  • Silence Therapeutics' Non-Current Receivables changed N/A to $40.9 million in Q2 2020 from the same period last year, while for Jun 2020 it was $40.9 million, marking a year-over-year change of. This contributed to the annual value of $5107.4 for FY2019, which is N/A changed from last year.
  • As of Q2 2020, Silence Therapeutics' Non-Current Receivables stood at $40.9 million.
  • Silence Therapeutics' Non-Current Receivables' 5-year high stood at $40.9 million during Q2 2020, with a 5-year trough of $5142.9 in Q4 2019.